Research and Development

QRSKIN GmbH works on a number of R&D projects in close collaboration with its affiliated company EVOMEDIS GmbH located in Graz (Austria). The R&D programs focus on the development of innovative solutions for the treatment of critical wounds. We work on further improvements of the epicitehydro wound dressing material as well as on line extensions of epicitehydro for new indications.

 

follow: